Repatha and Phenergan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Repatha (evolocumab) and Phenergan (promethazine hydrochloride). Common drug interactions include back pain among females and sciatica among males.

The phase IV clinical study analyzes what interactions people have when they take Repatha and Phenergan. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Repatha?

Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,258 Repatha users. Check the latest studies of Repatha.

What is Phenergan?

Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 25,312 Phenergan users. Check the latest studies of Phenergan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

11 people who take Repatha and Phenergan together, and have interactions are studied.

Repatha and Phenergan drug interactions.

What are the common drug interactions of Repatha and Phenergan, by gender? *:

female:

  1. Back pain
  2. Urticaria (rash of round, red welts on the skin that itch intensely)
  3. Arthralgia (joint pain)
  4. Chills (felling of cold)
  5. Dizziness
  6. Dyspnoea (difficult or laboured respiration)
  7. Influenza like illness
  8. Sleep disorder due to general medical condition, insomnia type (a conditions that prevent a person from getting restful sleep due to mental condition of not getting sleep)
  9. Upper respiratory tract infection
  10. Haematocrit decreased

male:

  1. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)

What are the common drug interactions of Repatha and Phenergan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Back pain
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Influenza like illness
  5. Pain
  6. Sleep disorder due to general medical condition, insomnia type (a conditions that prevent a person from getting restful sleep due to mental condition of not getting sleep)
  7. Upper respiratory tract infection
  8. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  9. Chest pain
  10. Dyspnoea (difficult or laboured respiration)

60+:

  1. Pain in extremity
  2. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  3. Fatigue (feeling of tiredness)
  4. Haematocrit decreased
  5. Haemoglobin decreased
  6. Injection site haematoma (localized swelling filled with blood at injection site)
  7. Injection site swelling
  8. Muscle spasms (muscle contraction)
  9. Oesophageal spasm (contraction of oesophagus)
  10. Pain in jaw

What are the existing conditions these people have? *

  1. Pain: 3 people, 27.27%
  2. Impaired Gastric Emptying: 3 people, 27.27%
  3. Muscle Spasms (muscle contraction): 3 people, 27.27%
  4. Nausea And Vomiting: 3 people, 27.27%
  5. Chest Pain: 2 people, 18.18%
  6. Migraine (headache): 2 people, 18.18%
  7. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 18.18%
  8. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 18.18%
  9. Thyroid Diseases: 2 people, 18.18%
  10. Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Repatha and Phenergan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Repatha and Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Repatha:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Repatha and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenergan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on evolocumab and promethazine hydrochloride (the active ingredients of Repatha and Phenergan, respectively), and Repatha and Phenergan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: